{"id":609,"date":"2020-10-07T21:21:41","date_gmt":"2020-10-07T19:21:41","guid":{"rendered":"https:\/\/blog.shp.law\/?p=609"},"modified":"2020-10-08T11:04:34","modified_gmt":"2020-10-08T09:04:34","slug":"prioritising-trade-mark-registration-for-covid-19-products-and-services","status":"publish","type":"post","link":"https:\/\/blog.shp.law\/index.php\/2020\/10\/07\/prioritising-trade-mark-registration-for-covid-19-products-and-services\/","title":{"rendered":"Prioritising Trade Mark Registration for COVID-19 products and services."},"content":{"rendered":"\n<p>The&nbsp;<a href=\"https:\/\/www.uspto.gov\/\" target=\"_blank\" rel=\"noreferrer noopener\">US Patent and Trademark Office<\/a>&nbsp;has announced a major new&nbsp;programme&nbsp;to enable applicants for trade mark registration for brand names for COVID-19 related medical products and services. It will be possible for an&nbsp;trade mark&nbsp;applicant to request acceleration of the trade mark registration process and the fees for prioritizing the examination will be waived.&nbsp;<\/p>\n\n\n\n<p>To be eligible, the&nbsp;trade mark&nbsp;application must be for one of the following medical goods or services:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Pharmaceutical products or medical devices such as diagnostic tests, ventilators, and personal protective equipment, including surgical masks, face shields, gowns, and gloves, that prevent, diagnose, treat, or cure COVID-19 and are subject to approval by the United States Food and Drug Administration&nbsp;<\/li><li>Medical services or medical research services for the prevention, diagnosis, treatment of, or cure for COVID-19&nbsp;<\/li><\/ul>\n\n\n\n<p>The application can also include other products.&nbsp;<\/p>\n\n\n\n<p>This is good news for applicants of&nbsp;US&nbsp;trade marks&nbsp;where the registration process can often take many months to complete. The prioritized examination will also open to European and other overseas applicants.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Currently there is no similar process in the&nbsp;<a href=\"https:\/\/euipo.europa.eu\/ohimportal\/en\/covid-19-information\" target=\"_blank\" rel=\"noreferrer noopener\">European IP Office<\/a>&nbsp;in operation. However,&nbsp;trade mark&nbsp;applications in Europe generally proceed to registration much quicker than in the United States.&nbsp;<\/p>\n\n\n\n<p>It\u2019s not clear how long this procedure will be in place. The official&nbsp;<a href=\"https:\/\/www.uspto.gov\/trademark\/laws-regulations\/covid-19-petition-prioritize-applications\" target=\"_blank\" rel=\"noreferrer noopener\">notice<\/a>&nbsp;on the US PTO\u2019s website gives no time limit.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The&nbsp;US Patent and Trademark Office&nbsp;has announced a major new&nbsp;programme&nbsp;to enable applicants for trade mark registration for brand names for COVID-19 related medical products and services. It will be possible for an&nbsp;trade mark&nbsp;applicant to request acceleration of the trade mark registration process and the fees for prioritizing the examination will be waived.&nbsp; To be eligible, the&nbsp;trade [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[42,41,40,35],"class_list":["post-609","post","type-post","status-publish","format-standard","hentry","category-general","tag-covid-19","tag-trademarks","tag-united-states","tag-uspto"],"_links":{"self":[{"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/posts\/609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/comments?post=609"}],"version-history":[{"count":0,"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/posts\/609\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/media?parent=609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/categories?post=609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.shp.law\/index.php\/wp-json\/wp\/v2\/tags?post=609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}